OM1, a Cambridge, Mass.-based startup focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare, has raised a series A financing round of $15 million.
OM1 says its system gathers, synthesizes, enriches and leverages clinical data to provide measurements and artificial intelligence-driven insights and predictions that can improve clinical, financial, and operational management. The company said its analytics can help healthcare organizations better optimize care for both individuals and populations, can inform smart supply chain decisions, and can provide a clearer link between outcomes and value — enabling risk-bearing entities to succeed under value-based care.
The company is led by CEO Richard Gliklich, M.D., who previously founded a company called Outcome, which he led from inception through its acquisition by Quintiles. His work has focused on registries, outcomes and analytics. He is senior editor of “Registries for Evaluating Patient Outcomes: A User's Guide” published by the U.S. Agency for Healthcare Research and Quality.
With the funding, led by General Catalyst and with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments, OM1 will continue the build-out of its outcomes measurement and machine learning technology.
“To improve healthcare across the board we need to fundamentally understand real-world results and become much better at both predicting at-risk patients and assessing potential treatment options for them,” Gliklich said in a prepared statement. “The system that we're building at OM1 will give providers unprecedented insight on the relationship between care and outcomes, helping them to avoid high-cost events and ultimately provide the best care possible. At the same time, we're focused on helping researchers and payers to more quickly and accurately generate real-world evidence and better understand the connection between outcomes and value.”
The funding announcement follows the addition of Gary Gottlieb, M.D., M.B.A., the CEO of Partners in Health and former President and CEO of Partners HealthCare, to the OM1 board of directors last year. In addition to his role at Partners in Health, Dr. Gottlieb is a professor of psychiatry at Harvard Medical School and serves as the chairman of the board of directors of the Federal Reserve Bank of Boston.
